pharmaceuticals-and-healthcare

United States Antibody Drug Conjugate Market Report 2017


Published On : Mar 2017

Category : Pharmaceutical

No. of Pages : 110 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Antibody Drug Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Antibody Drug Conjugate in these regions, from 2012 to 2022 (forecast).

United States Antibody Drug Conjugate market competition by top manufacturers/players, with Antibody Drug Conjugate sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Adcetris
Kadcyl
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody Drug Conjugate for each application, including
Hospital
Research Institutions

In the recent times, the global market for United states antibody drug conjugate market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states antibody drug conjugate market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states antibody drug conjugate market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states antibody drug conjugate market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states antibody drug conjugate market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states antibody drug conjugate market report 2017, including the definition, classification, and industry chain structure of United states antibody drug conjugate market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states antibody drug conjugate market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states antibody drug conjugate market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states antibody drug conjugate market report 2017, implemented in each of the geographical segments. The predominant applications of the United states antibody drug conjugate market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states antibody drug conjugate market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states antibody drug conjugate market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Antibody Drug Conjugate
Figure United States Antibody Drug Conjugate Market Size (K Pcs) by Type (2012-2022)
Figure United States Antibody Drug Conjugate Sales Volume Market Share by Type (Product Category) in 2016
Figure Adcetris Product Picture
Figure Kadcyl Product Picture
Figure United States Antibody Drug Conjugate Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Antibody Drug Conjugate by Application in 2016
Figure Hospital Examples
Figure Research Institutions Examples
Figure United States Antibody Drug Conjugate Market Size (Million USD) by Region (2012-2022)
Figure The West Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antibody Drug Conjugate Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Antibody Drug Conjugate Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Antibody Drug Conjugate Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody Drug Conjugate Sales Share by Players/Suppliers
Figure 2017 United States Antibody Drug Conjugate Sales Share by Players/Suppliers
Figure United States Antibody Drug Conjugate Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antibody Drug Conjugate Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antibody Drug Conjugate Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antibody Drug Conjugate Revenue Share by Players/Suppliers
Figure 2017 United States Antibody Drug Conjugate Revenue Share by Players/Suppliers
Table United States Market Antibody Drug Conjugate Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Antibody Drug Conjugate Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Antibody Drug Conjugate Market Share of Top 3 Players/Suppliers
Figure United States Antibody Drug Conjugate Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antibody Drug Conjugate Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antibody Drug Conjugate Product Category
Table United States Antibody Drug Conjugate Sales (K Pcs) by Region (2012-2017)
Table United States Antibody Drug Conjugate Sales Share by Region (2012-2017)
Figure United States Antibody Drug Conjugate Sales Share by Region (2012-2017)
Figure United States Antibody Drug Conjugate Sales Market Share by Region in 2016
Table United States Antibody Drug Conjugate Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antibody Drug Conjugate Revenue Share by Region (2012-2017)
Figure United States Antibody Drug Conjugate Revenue Market Share by Region (2012-2017)
Figure United States Antibody Drug Conjugate Revenue Market Share by Region in 2016
Table United States Antibody Drug Conjugate Price (USD/Pcs) by Region (2012-2017)
Table United States Antibody Drug Conjugate Sales (K Pcs) by Type (2012-2017)
Table United States Antibody Drug Conjugate Sales Share by Type (2012-2017)
Figure United States Antibody Drug Conjugate Sales Share by Type (2012-2017)
Figure United States Antibody Drug Conjugate Sales Market Share by Type in 2016
Table United States Antibody Drug Conjugate Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antibody Drug Conjugate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugate by Type (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugate by Type in 2016
Table United States Antibody Drug Conjugate Price (USD/Pcs) by Types (2012-2017)
Figure United States Antibody Drug Conjugate Sales Growth Rate by Type (2012-2017)
Table United States Antibody Drug Conjugate Sales (K Pcs) by Application (2012-2017)
Table United States Antibody Drug Conjugate Sales Market Share by Application (2012-2017)
Figure United States Antibody Drug Conjugate Sales Market Share by Application (2012-2017)
Figure United States Antibody Drug Conjugate Sales Market Share by Application in 2016
Table United States Antibody Drug Conjugate Sales Growth Rate by Application (2012-2017)
Figure United States Antibody Drug Conjugate Sales Growth Rate by Application (2012-2017)
Table Seattle Genetics/Takeda Basic Information List
Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Roche Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Roche Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table ImmunoGen Basic Information List
Table ImmunoGen Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Immunomedics Basic Information List
Table Immunomedics Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Pfizer Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Millennium Pharmaceuticals Basic Information List
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Mersana Therapeutics Basic Information List
Table Mersana Therapeutics Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Heidelberg Pharma Basic Information List
Table Heidelberg Pharma Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales Market Share in United States (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Revenue Market Share in United States (2012-2017)
Table Oxford BioTherapeutics Basic Information List
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Players/Suppliers in 2016
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure United States Antibody Drug Conjugate Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antibody Drug Conjugate Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Antibody Drug Conjugate Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antibody Drug Conjugate Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antibody Drug Conjugate Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Antibody Drug Conjugate Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antibody Drug Conjugate Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antibody Drug Conjugate Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Antibody Drug Conjugate Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Antibody Drug Conjugate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody Drug Conjugate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antibody Drug Conjugate Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top